Title
Pharmacologic Treatment of Spasticity in Children and Adolescents with Cerebral Palsy
Authoring Organizations
Publication Month/Year
January 26, 2010
Last Updated Month/Year
January 4, 2024
Supplemental Implementation Tools
Document Type
Guideline
External Publication Status
Published
Country of Publication
US
Document Objectives
To evaluate published evidence of efficacy and safety of pharmacologic treatments for childhood spasticity due to cerebral palsy.
Inclusion Criteria
Adolescent, Child
Health Care Settings
Ambulatory, Outpatient
Intended Users
Nurse, nurse practitioner, occupational therapist, physical therapist, physician, physician assistant, speech language pathologist
Scope
Treatment
Diseases/Conditions (MeSH)
D002547 - Cerebral Palsy
Keywords
movement disorder, cerebral palsy, muscle weakness, spasticity
Source Citation
Practice Parameter: Pharmacologic treatment of spasticity in children and adolescents with cerebral palsy (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. M. R. Delgado, D. Hirtz, M. Aisen, S. Ashwal, D. L. Fehlings, J. McLaughlin, L. A. Morrison, M. W. Shrader, A. Tilton, J. Vargus-Adams. Neurology Jan 2010, 74 (4) 336-343; DOI: 10.1212/WNL.0b013e3181cbcd2f